Prostate Cancer Treatment Cut to 5 Sessions
- Thousands of men in England to benefit from new treatment
- Treatment sessions reduced from 20 to 5
- SABR technique offers more effective targeting and fewer side effects
- Already used for lung and brain cancer patients
- Patients report equal satisfaction with new treatment
Thousands of men in England who have prostate cancer will be offered high-powered precision radiotherapy that will slash the number of treatment sessions they need from 20 to just five. Officials said the technique – called SABR (stereotactic ablative radiotherapy) - would target the disease more effectively than standard radiotherapy and help reduce side-effects. The treatment is already offered to some patients with other types of cancer, including lung and brain.
Senior doctors said the new treatment would significantly shorten hospital visits and treatment time.
Sources confirmed that the change was popular with patients, with five-year patient-reported outcomes showing that people considered the hypofractionated treatment to be equally as favorable as the standard treatment.
How the New Treatment Works
The SABR technique uses advanced radiotherapy technology to deliver high doses of radiation to the tumor site with greater precision. Nick Triggle, a health correspondent, said the treatment has been shown to be effective in reducing the number of treatment sessions needed.
Experts said the new treatment would improve patients' quality of life, with fewer treatment sessions meaning fewer unpleasant side effects, such as skin irritation, loss of appetite, nausea, and fatigue.
Witnesses said the treatment has been a game-changer for patients, allowing them to return to their normal lives more quickly.
Clinical Trials and Research
A randomized control trial involving 847 patients with prostate cancer showed that the SABR technique was effective in reducing the number of treatment sessions needed.
Government sources said the trial results were promising, with 90% of patients having intermediate-risk prostate cancer.
The trial compared the SABR technique with the current standard of care, which involves moderate hypofractionation radiotherapy. The results showed that the SABR technique was equally effective in treating the disease.
Historical Context of Prostate Cancer Treatment
Prostate cancer is one of the most common types of cancer affecting men in England.
Historically, treatment options have been limited, with patients often requiring multiple sessions of radiotherapy.
However, recent advances in medical technology have led to the development of new treatments, such as the SABR technique, which offer more effective and convenient options for patients.
Human Impact of the New Treatment
The new treatment is expected to have a significant impact on the lives of thousands of men in England who are diagnosed with prostate cancer each year.
Patients who have undergone the treatment have reported positive experiences, with many saying that it has allowed them to return to their normal lives more quickly.
Family members of patients have also reported a reduction in stress and anxiety, as the new treatment offers a more convenient and effective option for loved ones.